% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

  • gswkool gswkool Sep 23, 2013 12:31 PM Flag

    looked at options

    Have a 150% return so far and was looking to protect my position with Protective PUTS. However, the ones available were not worth much to me. I see {guess} 50% hit on downside if FDA flat out rejects, and 100% upside if approved on Oct 17th {barring any news that comes out in between}. The FDA does not always act rationally, so who knows what the outcome will be. I think in event of FDA rejection, PSDV will hold up better than ALIM since LLUVIEN is all ALIM has going for it. If FDA rejects LLUVIEN, I would expect ALIM to tank. Perhaps some time after it would make sense for the two companies to combine...PSDV gets other 80% of profits to be shared, ALIM gets a pipeline, and they both can reduce operating overheads.......anyhow...GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • PSDV mkt cap will be $50 million with a 50% hit per ur prediction. So EU approval and the rest of the pipeline (includ Ph3 + tethadur + ph3 pancreatic cancer) is worth $50 million ?? Seriously???

      • 1 Reply to balram79
      • While I'm a fan of PSDV and made a lot of money on it {so far}, the market is unfortunately not giving PSDV much value for its other assets. If it were, I think the market cap would be much higher today than it is now. In my valuation, I did say "barring any news that comes out in between". If we get some good news before the 17th related to one of their other pipeline activities, of course the shares will move higher then, and may not fall as far. I'm certainly hoping for that to happen....

3.01-0.17(-5.35%)Sep 30 4:00 PMEDT